197 related articles for article (PubMed ID: 35154097)
21. Tumor-induced apoptosis of human IL-2-activated NK cells: role of natural cytotoxicity receptors.
Poggi A; Massaro AM; Negrini S; Contini P; Zocchi MR
J Immunol; 2005 Mar; 174(5):2653-60. PubMed ID: 15728472
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.
Kundu K; Ghosh S; Sarkar R; Edri A; Brusilovsky M; Gershoni-Yahalom O; Yossef R; Shemesh A; Soria JC; Lazar V; Joshua BZ; Campbell KS; Elkabets M; Porgador A
Cancer Immunol Res; 2019 Jul; 7(7):1120-1134. PubMed ID: 31164357
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies.
Dorsch M; Urlaub D; Bönnemann V; Bröde P; Sandusky M; Watzl C
Eur J Immunol; 2020 May; 50(5):656-665. PubMed ID: 32027754
[TBL] [Abstract][Full Text] [Related]
24. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
[TBL] [Abstract][Full Text] [Related]
25. Natural Cytotoxicity Receptors in Decidua Natural Killer Cells of Term Normal Pregnancy.
Takahashi H; Yamamoto T; Yamazaki M; Murase T; Matsuno T; Chishima F
J Pregnancy; 2018; 2018():4382084. PubMed ID: 30155304
[TBL] [Abstract][Full Text] [Related]
26. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.
Jarahian M; Watzl C; Fournier P; Arnold A; Djandji D; Zahedi S; Cerwenka A; Paschen A; Schirrmacher V; Momburg F
J Virol; 2009 Aug; 83(16):8108-21. PubMed ID: 19515783
[TBL] [Abstract][Full Text] [Related]
27. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines.
Sivori S; Parolini S; Marcenaro E; Millo R; Bottino C; Moretta A
Hum Immunol; 2000 Nov; 61(11):1055-8. PubMed ID: 11137207
[TBL] [Abstract][Full Text] [Related]
28. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
[TBL] [Abstract][Full Text] [Related]
29. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
Hromadnikova I; Pirkova P; Sedlackova L
Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
[TBL] [Abstract][Full Text] [Related]
30. Unlike natural killer (NK) p30, natural cytotoxicity receptor NKp44 binds to multimeric α2,3-NeuNAc-containing N-glycans.
Ito K; Higai K; Shinoda C; Sakurai M; Yanai K; Azuma Y; Matsumoto K
Biol Pharm Bull; 2012; 35(4):594-600. PubMed ID: 22466566
[TBL] [Abstract][Full Text] [Related]
31. NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
Campbell KS; Yusa S; Kikuchi-Maki A; Catina TL
J Immunol; 2004 Jan; 172(2):899-906. PubMed ID: 14707061
[TBL] [Abstract][Full Text] [Related]
32. Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes.
Białoszewska A; Baychelier F; Niderla-Bielińska J; Czop A; Debré P; Vieillard V; Kieda C; Malejczyk J
Cell Immunol; 2013; 285(1-2):6-9. PubMed ID: 24044960
[TBL] [Abstract][Full Text] [Related]
33. Natural killer cells in acute myeloid leukemia patients: from phenotype to transcriptomic analysis.
Venton G; Labiad Y; Colle J; Fino A; Afridi S; Torres M; Monteuil S; Loriod B; Fernandez-Nunez N; Farnault L; Suchon P; Mattei JC; Rihet P; Bergon A; Nguyen C; Baier C; Costello R
Immunol Res; 2016 Dec; 64(5-6):1225-1236. PubMed ID: 27481509
[TBL] [Abstract][Full Text] [Related]
34. NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.
Parodi M; Favoreel H; Candiano G; Gaggero S; Sivori S; Mingari MC; Moretta L; Vitale M; Cantoni C
Front Immunol; 2019; 10():719. PubMed ID: 31024551
[TBL] [Abstract][Full Text] [Related]
35. Profile of natural killer cells after a previous natural Vaccinia virus infection in an in vitro viral re-exposure.
Moreira-Silva EA; Medeiros-Silva DC; Gomes Jde A; da Fonseca FG; Correa-Oliveira R
Virus Res; 2014 May; 184():20-9. PubMed ID: 24530576
[TBL] [Abstract][Full Text] [Related]
36. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
[TBL] [Abstract][Full Text] [Related]
37. Identification of a cellular ligand for the natural cytotoxicity receptor NKp44.
Baychelier F; Sennepin A; Ermonval M; Dorgham K; Debré P; Vieillard V
Blood; 2013 Oct; 122(17):2935-42. PubMed ID: 23958951
[TBL] [Abstract][Full Text] [Related]
38. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
39. Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1.
Glasner A; Ghadially H; Gur C; Stanietsky N; Tsukerman P; Enk J; Mandelboim O
J Immunol; 2012 Mar; 188(6):2509-15. PubMed ID: 22308311
[TBL] [Abstract][Full Text] [Related]
40. Modulation the expression of natural killer cell activating receptor (NKp44) in the peripheral blood of diffuse large B-cell lymphoma patients and the correlation with clinic pathological features.
Essa ES; Tawfeek GA; El Hassanin SA; Emara KGM
Clin Immunol; 2018 Mar; 188():38-44. PubMed ID: 29247708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
